SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007596
Filing Date
2019-08-08
Accepted
2019-08-08 08:29:37
Documents
45
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q albo-20190630x10q.htm 10-Q 1475482
2 EX-31.1 albo-20190630ex311e3b469.htm EX-31.1 11739
3 EX-31.2 albo-20190630ex312540697.htm EX-31.2 11640
4 EX-32.1 albo-20190630ex3211d9ffb.htm EX-32.1 12221
  Complete submission text file 0001558370-19-007596.txt   3487040

Data Files

Seq Description Document Type Size
5 EX-101.INS albo-20190630.xml EX-101.INS 439633
6 EX-101.SCH albo-20190630.xsd EX-101.SCH 26298
7 EX-101.CAL albo-20190630_cal.xml EX-101.CAL 29636
8 EX-101.DEF albo-20190630_def.xml EX-101.DEF 73413
9 EX-101.LAB albo-20190630_lab.xml EX-101.LAB 248197
10 EX-101.PRE albo-20190630_pre.xml EX-101.PRE 165889
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33451 | Film No.: 191007585
SIC: 2834 Pharmaceutical Preparations